Albany molecular research INC - rosenzweig
Ended Awarded Last action
- Contract number
- 75N95019F00090
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,022,104
Award facts
- Contract value 37% obligated
-
- $1,022,104.13 Current, with exercised options
- $2,755,155.31 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$3 | |
| Funding Only Action | $162,845 | |
| Original award | $859,262 |
About this award
This is a federal contract award to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The award, with a ceiling value of $2,755,155.31, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, under the Drug Manufacturing and Formulation Program (DMFP) indefinite-delivery/indefinite-quantity (IDIQ) contract. The contract is a delivery order and has a pricing type of cost plus fixed fee. The award supports Curia's provision of a wide range of pharmaceutical research and development services to NINDS, spanning early-stage drug discovery through commercialization, including medicinal chemistry, chemical development, analytical testing, formulation development, and cGMP manufacturing. This award is not designated as a set-aside contract.
Quick answers
Who was awarded contract 75N95019F00090?
75N95019F00090 was awarded to Curia Global Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 16, 2019.
How much is contract 75N95019F00090 worth?
The government has obligated $1,022,104 on 75N95019F00090. Its potential value, with all options, is $2,755,155.
Which agency awarded contract 75N95019F00090?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00090, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Is contract 75N95019F00090 an order under another contract?
Yes. 75N95019F00090 is a delivery order under HHSN271201500005I, an indefinite delivery contract, on Drug Manufacturing and Formulation Program (DMFP).
Was contract 75N95019F00090 competed?
The extent of competition for 75N95019F00090 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award